618 related articles for article (PubMed ID: 10938327)
41. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T
J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
[TBL] [Abstract][Full Text] [Related]
42. Axotomy reduces the effect of analgesic opioids yet increases the effect of nociceptin on dorsal root ganglion neurons.
Abdulla FA; Smith PA
J Neurosci; 1998 Dec; 18(23):9685-94. PubMed ID: 9822729
[TBL] [Abstract][Full Text] [Related]
43. Encoding of corneal input in two distinct regions of the spinal trigeminal nucleus in the rat: cutaneous receptive field properties, responses to thermal and chemical stimulation, modulation by diffuse noxious inhibitory controls, and projections to the parabrachial area.
Meng ID; Hu JW; Benetti AP; Bereiter DA
J Neurophysiol; 1997 Jan; 77(1):43-56. PubMed ID: 9120584
[TBL] [Abstract][Full Text] [Related]
44. Antinociception produced by receptor selective opioids: modulation of spinal antinociceptive effects by supraspinal opioids.
Miaskowski C; Levine JD
Brain Res; 1992 Nov; 595(1):32-8. PubMed ID: 1334770
[TBL] [Abstract][Full Text] [Related]
45. Spinal mu and delta, but not kappa, opioid-receptor agonists attenuate responses to noxious colorectal distension in the rat.
Danzebrink RM; Green SA; Gebhart GF
Pain; 1995 Oct; 63(1):39-47. PubMed ID: 8577489
[TBL] [Abstract][Full Text] [Related]
46. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
Devine DP; Leone P; Pocock D; Wise RA
J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399
[TBL] [Abstract][Full Text] [Related]
47. Differential cross-tolerance between analgesia produced by alpha 2-adrenoceptor agonists and receptor subtype selective opioid treatments.
Paul D; Tran JG
Eur J Pharmacol; 1995 Jan; 272(1):111-4. PubMed ID: 7713142
[TBL] [Abstract][Full Text] [Related]
48. Mu and delta opioid receptor regulation of pro-opiomelanocortin peptide secretion from the rat neurointermediate pituitary in vitro.
Carr JA; Lovering AT
Neuropeptides; 2000 Feb; 34(1):69-75. PubMed ID: 10688972
[TBL] [Abstract][Full Text] [Related]
49. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
[TBL] [Abstract][Full Text] [Related]
50. Endogenous opioid peptides acting at mu-opioid receptors in the dorsal horn contribute to midbrain modulation of spinal nociceptive neurons.
Budai D; Fields HL
J Neurophysiol; 1998 Feb; 79(2):677-87. PubMed ID: 9463431
[TBL] [Abstract][Full Text] [Related]
51. Mu and kappa opioid agonists modulate ventral tegmental area input to the ventral pallidum.
Mitrovic I; Napier TC
Eur J Neurosci; 2002 Jan; 15(2):257-68. PubMed ID: 11849293
[TBL] [Abstract][Full Text] [Related]
52. Intracisternal injection of opioids induces itch-associated response through mu-opioid receptors in mice.
Tohda C; Yamaguchi T; Kuraishi Y
Jpn J Pharmacol; 1997 May; 74(1):77-82. PubMed ID: 9195300
[TBL] [Abstract][Full Text] [Related]
53. Opioids modulate N-methyl-D-aspartic acid (NMDA)-evoked responses of trigeminothalamic neurons.
Wang XM; Mokha SS
J Neurophysiol; 1996 Sep; 76(3):2093-6. PubMed ID: 8890319
[TBL] [Abstract][Full Text] [Related]
54. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice.
Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1989 Jun; 249(3):762-8. PubMed ID: 2567350
[TBL] [Abstract][Full Text] [Related]
55. Effect of chronic administration of morphine, U-50, 488H and [D-Pen2, D-Pen5]enkephalin on the concentration of cGMP in brain regions and spinal cord of the mouse.
Bhargava HN; Cao YJ
Peptides; 1997; 18(10):1629-34. PubMed ID: 9437726
[TBL] [Abstract][Full Text] [Related]
56. Opioid actions on neurons of rat lateral amygdala in vitro.
Sugita S; North RA
Brain Res; 1993 May; 612(1-2):151-5. PubMed ID: 8101129
[TBL] [Abstract][Full Text] [Related]
57. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
58. Opioidergic modulation of excitability of rat trigeminal root ganglion neuron projections to the superficial layer of cervical dorsal horn.
Takeda M; Tanimoto T; Ikeda M; Kadoi J; Nasu M; Matsumoto S
Neuroscience; 2004; 125(4):995-1008. PubMed ID: 15120859
[TBL] [Abstract][Full Text] [Related]
59. The possible involvement of endogenous ligands for mu-, delta- and kappa-opioid receptors in modulating morphine-induced CPP expression in rats.
Liang J; Li Y; Ping X; Yu P; Zuo Y; Wu L; Han JS; Cui C
Peptides; 2006 Dec; 27(12):3307-14. PubMed ID: 17097192
[TBL] [Abstract][Full Text] [Related]
60. Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptors.
Xu H; Wang X; Partilla JS; Bishop-Mathis K; Benaderet TS; Dersch CM; Simpson DS; Prisinzano TE; Rothman RB
Brain Res Bull; 2008 Sep; 77(1):49-54. PubMed ID: 18639745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]